Versant Capital Management
KURA icon

Versant Capital Management’s Kura Oncology KURA Stock Holding History

Versant Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.6K Hold
1,272
– – ﹤0.01% 2148
2026
Q2 		$14K Hold
1,272
– – ﹤0.01% 2109
2026
Q1 		$10.3K Hold
1,272
– – ﹤0.01% 2128
2025
Q4 		$13.2K Hold
1,272
– – ﹤0.01% 1877
2025
Q3 		$11.3K Buy
1,272
+36
+3% +$257 ﹤0.01% 1882
2025
Q2 		$7.13K Buy
1,236
+272
+28% +$1.67K ﹤0.01% 2041
2025
Q1 		$6.36K Buy
+964
New +$7.51K ﹤0.01% 1932

Other funds holding KURA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alethea Capital Management
Alethea Capital Management Mercer Island, Washington $197M AUM 51.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Jupiter Asset Management
Jupiter Asset Management London, United Kingdom $21.4B AUM 19.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Versant Capital Management's KURA Position: Q3 2026 in Review

Versant Capital Management held its Kura Oncology (KURA) position steady in Q3 2026 at 1,272 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2148.

Versant Capital Management first reported a position in KURA in Q1 2025 and has held it in 7 quarters since. The position peaked at $14K in Q2 2026. 177 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Versant Capital Management held 1,272 shares of Kura Oncology worth $13.6K as of Q3 2026.
  • Versant Capital Management left its Kura Oncology share count unchanged in Q3 2026.
  • Kura Oncology made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2148 holding.
  • Versant Capital Management first reported a position in Kura Oncology in Q1 2025 and has held it in 7 quarters since.
  • Versant Capital Management's Kura Oncology position peaked at $14K in Q2 2026.
  • 177 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.